UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank

Cell stem cell, 2020-04, Vol.26 (4), p.503-510.e7

2020

Volltextzugriff (PDF)

Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis

PloS one, 2015-01, Vol.10 (1), p.e0116029-e0116029

2015

Volltextzugriff (PDF)

Ion mobility-tandem mass spectrometry of mucin-type O-glycans

Nature communications, 2024-03, Vol.15 (1), p.2611-2611, Article 2611

2024

Volltextzugriff (PDF)

Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis

International journal of molecular sciences, 2023-08, Vol.24 (15), p.12365

2023

Volltextzugriff (PDF)

Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis

Frontiers in pharmacology, 2023-04, Vol.14, p.1179208-1179208

2023

Volltextzugriff (PDF)

Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis

Frontiers in microbiology, 2022-05, Vol.13, p.885822-885822

2022

Volltextzugriff (PDF)

The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches

The Lancet (British edition), 2023-09, Vol.402 (10408), p.1185-1198

2023

Volltextzugriff (PDF)

Effects of lumacaftor-ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 years

Frontiers in pharmacology, 2023-05, Vol.14, p.1188051-1188051

2023

Volltextzugriff (PDF)

Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis

Journal of personalized medicine, 2021-05, Vol.11 (5), p.384

2021

Volltextzugriff (PDF)

Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging

Frontiers in pharmacology, 2023-04, Vol.14, p.1161891-1161891

2023

Volltextzugriff (PDF)

A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis

Frontiers in cellular and infection microbiology, 2021-12, Vol.11, p.763121-763121

2021

Volltextzugriff (PDF)

Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis

Mediators of inflammation, 2017-01, Vol.2017 (2017), p.1-10

2017

Volltextzugriff (PDF)

Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis

American journal of respiratory and critical care medicine, 2017-02, Vol.195 (3), p.349-359

2017

Volltextzugriff (PDF)

Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosis

ERJ open research, 2023-03, Vol.9 (2), p.473

2023

Volltextzugriff (PDF)

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles

American journal of respiratory and critical care medicine, 2022-03, Vol.205 (5), p.540-549

2022

Volltextzugriff (PDF)

Depression Symptoms in Patients with Cystic Fibrosis Fluctuate at Baseline and Improve with Elexacaftor/Tezacaftor/Ivacaftor Therapy

American journal of respiratory and critical care medicine, 2024-08, Vol.210 (3), p.365-367

2024

Volltextzugriff (PDF)

Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis

The European respiratory journal, 2023-08, Vol.62 (2), p.2202153

2023

Volltextzugriff (PDF)

TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease

Frontiers in medicine, 2023-01, Vol.9, p.1034290-1034290

2023

Volltextzugriff (PDF)

Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study

American journal of respiratory and critical care medicine, 2019-05, Vol.199 (10), p.1238-1248

2019

Volltextzugriff (PDF)

Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis

American journal of respiratory and critical care medicine, 2018-06, Vol.197 (11), p.1433-1442

2018

Volltextzugriff (PDF)

Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis

American journal of respiratory and critical care medicine, 2021-10, Vol.204 (8), p.943-953

2021

Volltextzugriff (PDF)

Effects of Lumacaftor-Ivacaftor on Lung Clearance Index, Magnetic Resonance Imaging, and Airway Microbiome in Phe508del Homozygous Patients with Cystic Fibrosis

Annals of the American Thoracic Society, 2021-06, Vol.18 (6), p.971-980

2021

Volltextzugriff (PDF)

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles

American journal of respiratory and critical care medicine, 2022-08, Vol.206 (3), p.311-320

2022

Volltextzugriff (PDF)

Lack of Neutrophil Elastase Reduces Inflammation, Mucus Hypersecretion, and Emphysema, but Not Mucus Obstruction, in Mice with Cystic Fibrosis-like Lung Disease

American journal of respiratory and critical care medicine, 2014-05, Vol.189 (9), p.1082-1092

2014

Volltextzugriff (PDF)

A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases

The European respiratory journal, 2023-05, Vol.61 (5), p.2202022

2023

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(50)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(39)
Cystic Fibrosis
(36)
Respiratory System
(23)
Humans
(22)
General & Internal Medicine
(14)
Critical Care Medicine
(11)
Female
(11)
Magnetic Resonance Imaging
(11)
Male
(11)
Lung Diseases
(10)
Adolescent
(9)
Child
(9)
Mutation
(9)
Cystic Fibrosis - Drug Therapy
(8)
Cystic Fibrosis - Genetics
(8)
Aminophenols - Therapeutic Use
(7)
Cystic Fibrosis - Physiopathology
(7)
Cystic Fibrosis Transmembrane Conductance Regulator - Genetics
(6)
Inflammation
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank

Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis

Ion mobility-tandem mass spectrometry of mucin-type O-glycans

Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis

Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis

Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis

The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches

Effects of lumacaftor-ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 years

Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis

Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging

A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis

Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis

Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis

Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosis

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles

Depression Symptoms in Patients with Cystic Fibrosis Fluctuate at Baseline and Improve with Elexacaftor/Tezacaftor/Ivacaftor Therapy

Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis

TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease

Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study

Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis

Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis

Effects of Lumacaftor-Ivacaftor on Lung Clearance Index, Magnetic Resonance Imaging, and Airway Microbiome in Phe508del Homozygous Patients with Cystic Fibrosis

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles

Lack of Neutrophil Elastase Reduces Inflammation, Mucus Hypersecretion, and Emphysema, but Not Mucus Obstruction, in Mice with Cystic Fibrosis-like Lung Disease

A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases

Suchergebnisse filtern